Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 | --- | |------------------------------------------------------------------------| | | | For the transition period from to | | Commission file number 1-5975 | | HUMANA INC. | | (Exa ...

Humana, Inc. (NYSE:HUM) Q2 2024 Earnings Conference Call July 31, 2024 9:00 AM ET Company Participants Lisa Stoner - Vice President, Investor Relations James Rechtin - President and Chief Executive Officer Susan Diamond - Chief Financial Officer Conference Call Participants Ann Hynes - Mizuho Sarah James - Cantor Fitzgerald Andrew Mok - Barclays Justin Lake - Wolfe Research David Windley - Jefferies A.J. Rice - UBS Kevin Fischbeck - Bank of America Josh Raskin - Nephron Research Ben Hendrix - RBC Capital Ma ...

Humana (HUM) came out with quarterly earnings of $6.96 per share, beating the Zacks Consensus Estimate of $5.89 per share. This compares to earnings of $8.94 per share a year ago. These figures are adjusted for nonrecurring items. Over the last four quarters, the company has surpassed consensus EPS estimates three times. Humana shares have lost about 11.6% since the beginning of the year versus the S&P 500's gain of 14%. There are no easy answers to this key question, but one reliable measure that can help ...

FOR MORE INFORMATION CONTACT: • Reports 2Q24 earnings per share (EPS) of $5.62 on a GAAP basis, Adjusted EPS of $6.96; reports YTD 2024 EPS of $11.74 on a GAAP basis, $14.19 on an Adjusted basis • Revises FY 2024 EPS guidance to 'approximately $12.81' (previously 'approximately $13.93') on a GAAP basis, while affirming Adjusted EPS of 'approximately $16.00'; affirms FY 2024 Insurance segment benefit ratio of approximately 90 percent • Raises 2024 individual Medicare Advantage annual membership growth by 75, ...

Shareholders who purchased shares of HUM during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CLASS PERIOD: July 27, 2022 to January 24, 2024 NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of HUM during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lif ...

NEW YORK, July 29, 2024 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds investors a shareholder filed a class action lawsuit on behalf of all purchasers of common stock of Humana Inc. (NYSE: HUM) between July 27, 2022 and January 24, 2024. Shareholders who want to serve as lead plaintiff for the class must file their motions with the court by August 2, 2024. The Rosen Law Firm is investigating the Allegations that Humana Inc. (NYSE: HUM) Misled Investors Regarding its Business Ope ...

Humana Inc. (HUM) is set to report its second-quarter 2024 results on Jul 31, before the opening bell. The Zacks Consensus Estimate for second-quarter earnings per share of $5.89 indicates a decrease of 34.1% from the prior-year reported number of $8.94. The estimate remained stable over the past week. The consensus mark for second-quarter revenues of $28.6 billion indicates an 11.3% increase from the year-ago reported figure. Image Source: Zacks Investment Research Humana beat the earnings estimate in thre ...

Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock. The collective assessment of analysts points to an estimated 'Revenues- Investment income (loss)' of $304.69 million. The esti ...

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Humana Inc. (NYSE: HUM) between July 27, 2022 and January 24, 2024, both dates inclusive (the "Class Period"), of the important August 2, 2024 lead plaintiff deadline. WHAT TO DO NEXT: To join the Humana class action, go to https://rosenlegal.com/submit-form/? case_id=25679 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action. A class action lawsuit ha ...

NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Humana Inc. ("Humana" or the "Company") (NYSE: HUM) and reminds investors of the August 2, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading st ...